EP 1858490 B1 20120411 - PHARMACEUTICAL FORMS WITH IMPROVED PHARMACOKINETIC PROPERTIES
Title (en)
PHARMACEUTICAL FORMS WITH IMPROVED PHARMACOKINETIC PROPERTIES
Title (de)
ARZNEIFORMEN MIT VERBESSERTEN PHARMAKOKINETISCHEN EIGENSCHAFTEN
Title (fr)
FORMES PHARMACEUTIQUES A PROPRIETES PHARMACOCINETIQUES AMELIOREES
Publication
Application
Priority
- EP 2006001393 W 20060216
- DE 102005009240 A 20050301
Abstract (en)
[origin: WO2006092207A1] The invention relates to novel pharmaceutical formulations of Vardenafil, which rapidly dissolve in the mouth and lead to an increase in bioavailability and a plateau-shaped plasma concentration curve and method for production thereof.
IPC 8 full level
A61K 9/22 (2006.01); A61K 31/53 (2006.01)
CPC (source: EP KR NO US)
A61K 9/0056 (2013.01 - EP NO US); A61K 9/006 (2013.01 - EP US); A61K 9/20 (2013.01 - KR); A61K 9/2013 (2013.01 - NO); A61K 9/2018 (2013.01 - NO US); A61K 31/53 (2013.01 - EP KR NO US); A61P 15/00 (2018.01 - EP); A61P 15/10 (2018.01 - EP); A61P 43/00 (2018.01 - EP)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK YU
DOCDB simple family (publication)
DE 102005009240 A1 20060907; AR 053552 A1 20070509; AR 111572 A2 20190731; AT E552828 T1 20120415; AU 2006220100 A1 20060908; AU 2006220100 B2 20110818; BR PI0609375 A2 20100330; CA 2599617 A1 20060908; CA 2599617 C 20120110; CN 101141950 A 20080312; CN 101141950 B 20110608; CN 102198140 A 20110928; CN 102198140 B 20160608; CR 20130381 A 20130912; CR 9339 A 20071217; CY 1112874 T1 20160413; DK 1858490 T3 20120723; DO P2006000049 A 20061031; EP 1858490 A1 20071128; EP 1858490 B1 20120411; EP 2377523 A1 20111019; ES 2384109 T3 20120629; GT 200600097 A 20061113; HK 1118457 A1 20090213; HN 2006009000 A 20100805; HR P20120545 T1 20120731; IL 185552 A0 20080106; IL 185552 A 20170629; IL 246548 A0 20160831; JP 2008531614 A 20080814; JP 5122984 B2 20130116; KR 101360526 B1 20140221; KR 20070110109 A 20071115; MA 29376 B1 20080401; MX 2007010527 A 20071108; MY 148698 A 20130531; MY 177386 A 20200914; NO 20074848 L 20070927; NO 20120203 L 20070927; NO 332368 B1 20120903; NO 344546 B1 20200127; NZ 561004 A 20101224; PE 20061015 A1 20061020; PE 20100740 A1 20101028; PL 1858490 T3 20120928; PT 1858490 E 20120619; RS 52374 B 20121231; RU 2007135982 A 20090410; RU 2011111106 A 20120927; RU 2423970 C2 20110720; RU 2481110 C2 20130510; SG 160330 A1 20100429; SI 1858490 T1 20120731; TN SN07336 A1 20081231; TW 200640503 A 20061201; TW I387465 B 20130301; UA 93200 C2 20110125; US 2008249096 A1 20081009; US 2014186444 A1 20140703; US 8613950 B2 20131224; UY 29395 A1 20061002; WO 2006092207 A1 20060908; ZA 200707320 B 20090826
DOCDB simple family (application)
DE 102005009240 A 20050301; AR P060100745 A 20060228; AR P180100644 A 20180320; AT 06706994 T 20060216; AU 2006220100 A 20060216; BR PI0609375 A 20060216; CA 2599617 A 20060216; CN 200680006596 A 20060216; CN 201110078538 A 20060216; CR 20130381 A 20130807; CR 9339 A 20070827; CY 121100558 T 20120620; DK 06706994 T 20060216; DO 2006000049 A 20060222; EP 06706994 A 20060216; EP 11172872 A 20060216; EP 2006001393 W 20060216; ES 06706994 T 20060216; GT 200600097 A 20060227; HK 08109907 A 20080905; HN 2006009000 A 20060301; HR P20120545 T 20120705; IL 18555207 A 20070828; IL 24654816 A 20160630; JP 2007557361 A 20060216; KR 20077022210 A 20060216; MA 30265 A 20071001; MX 2007010527 A 20060216; MY PI20060864 A 20060228; MY PI2011005219 A 20060228; NO 20074848 A 20070924; NO 20120203 A 20120224; NZ 56100406 A 20060216; PE 2006000230 A 20060228; PE 2010000018 A 20060228; PL 06706994 T 20060216; PT 06706994 T 20060216; RS P20120256 A 20060216; RU 2007135982 A 20060216; RU 2011111106 A 20110324; SG 2010011658 A 20060216; SI 200631352 T 20060216; TN SN07336 A 20070831; TW 95106484 A 20060227; UA A200710870 A 20060216; US 201314107696 A 20131216; US 88501906 A 20060216; UY 29395 A 20060224; ZA 200707320 A 20070829